PMC:2700745 / 6658-6924
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/2700745","sourcedb":"PMC","sourceid":"2700745","source_url":"https://www.ncbi.nlm.nih.gov/pmc/2700745","text":"Approved therapeutics Approved therapeutics for seasonal influenza A virus infections include the neuraminidase inhibitors oseltamivir phosphate (Tamiflu®) and zanamivir (Relenza®) and the M2 ion channel blockers amantadine (Symmetrel®) and rimantadine (Flumadine®).","divisions":[{"label":"td","span":{"begin":0,"end":21}}],"tracks":[]}